secwatch.observer — SEC 8-K summary
======================================

Issuer:     PULSE BIOSCIENCES, INC. (PLSE)
CIK:        0001625101
Form:       8-K
Filed at:   2026-04-16T23:59:59+00:00
Accession:  0001437749-26-012498
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulse Biosciences posts investor deck with nsPFA cath lab study details and 2026 goals
--------------------------------------------------------------------------------

- New details disclosed on pivotal clinical study of nsPFA Cardiac Catheter for atrial fibrillation.
- Next-generation nPulse cardiac catheter under development described in the deck.
- 2026 corporate goals summarized across electrophysiology, cardiac surgery, and soft tissue ablation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625101/000143774926012498/0001437749-26-012498-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625101/000143774926012498/plse20260415_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-012498

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer